|
1
|
Jain A and McNamara PJ: Persistent
pulmonary hypertension of the newborn: Advances in diagnosis and
treatment. Semin Fetal Neonatal Med. 20:262–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Keith IM, Tjen-A-Looi S, Kraiczi H and
Ekman R: Three-week neonatal hypoxia reduces blood CGRP and causes
persistent pulmonary hypertension in rats. Am J Physiol Heart Circ
Physiol. 279:H1571–H1578. 2000.PubMed/NCBI
|
|
3
|
Afolayan AJ, Eis A, Alexander M,
Michalkiewicz T, Teng RJ, Lakshminrusimha S and Konduri GG:
Decreased endothelial nitric oxide synthase expression and function
contribute to impaired mitochondrial biogenesis and oxidative
stress in fetal lambs with persistent pulmonary hypertension. Am J
Physiol Lung Cell Mol Physiol. 310:L40–L49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steinhorn RH: Neonatal pulmonary
hypertension. Pediatr Crit Care Med. 11 2 Suppl:79–84. 2010.
View Article : Google Scholar
|
|
5
|
Postolow F, Fediuk J, Nolette N, Hinton M
and Dakshinamurti S: Thromboxane promotes smooth muscle phenotype
commitment but not remodeling of hypoxic neonatal pulmonary artery.
Fibrogenesis Tissue Repair. 8:202015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sluiter I, Reiss I, Kraemer U, Krijger Rd,
Tibboel D and Rottier RJ: Vascular abnormalities in human newborns
with pulmonary hypertension. Expert Rev Respir Med. 5:245–256.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo SJ, Wang T, Jia LQ, Li DD, Shen YC, Xu
D and Wen FQ: TRAM-34 attenuates hypoxia induced pulmonary artery
smooth muscle cell proliferation. Eur Rev Med Pharmacol Sci.
19:3515–3521. 2015.PubMed/NCBI
|
|
8
|
Wan J, Yamamura A, Zimnicka AM, Voiriot G,
Smith KA, Tang H, Ayon RJ, Choudhury MS, Ko EA, Wang J, et al:
Chronic hypoxia selectively enhances L- and T-type
voltage-dependent Ca2+ channel activity in pulmonary
artery by upregulating Cav1.2 and Cav3.2. Am J Physiol Lung Cell
Mol Physiol. 305:L154–L164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamamura A, Yamamura H, Zeifman A and Yuan
JX: Activity of Ca -activated Cl channels contributes to regulating
receptor- and store-operated Ca entry in human pulmonary artery
smooth muscle cells. Pulm Circ. 1:269–279. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Lu W, Yang K, Wang Y, Zhang J, Jia
J, Yun X, Tian L, Chen Y, Jiang Q, et al: Peroxisome
proliferator-activated receptor gamma inhibits pulmonary
hypertension targeting store-operated calcium entry. J Mol Med
(Berl). 93:327–342. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang K, Lu W, Jiang Q, Yun X, Zhao M,
Jiang H and Wang J: Peroxisome proliferator-activated receptor
γ-mediated inhibition on hypoxia-triggered store-operated calcium
entry. A caveolin-1-dependent mechanism. Am J Respir Cell Mol Biol.
53:882–892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nawar NN, Mohamed AH, Adieb N and Emad M:
The effect of maternal Naja nigricollis envenomation on the
placenta. An experimental study. Biol Struct Morphog. 2:13–17.
1989.PubMed/NCBI
|
|
13
|
Zhang D, Wang G, Han D, Zhang Y, Xu J, Lu
J, Li S, Xie X, Liu L, Dong L and Li M: Activation of PPAR-γ
ameliorates pulmonary arterial hypertension via inducing heme
oxygenase-1 and p21(WAF1): An in vivo study in rats. Life Sci.
98:39–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takano H and Komuro I: Peroxisome
proliferator-activated receptor gamma and cardiovascular diseases.
Circ J. 73:214–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Behringer A, Trappiel M, Berghausen EM,
Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F,
Gassanov N, Rosenkranz S, et al: Pioglitazone alleviates cardiac
and vascular remodelling and improves survival in monocrotaline
induced pulmonary arterial hypertension. Naunyn Schmiedebergs Arch
Pharmacol. 389:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hansmann G, de Jesus Perez VA, Alastalo
TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T,
Wang L, Morrell NW and Rabinovitch M: An antiproliferative
BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in
pulmonary hypertension. J Clin Invest. 118:1846–1857. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bijli KM, Kleinhenz JM, Murphy TC, Kang
BY, Adesina SE, Sutliff RL and Hart CM: Peroxisome
proliferator-activated receptor gamma depletion stimulates Nox4
expression and human pulmonary artery smooth muscle cell
proliferation. Free Radic Biol Med. 80:111–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie X, Wang G, Zhang D, Zhang Y, Zhu Y, Li
F, Li S and Li M: Activation of peroxisome proliferator-activated
receptor γ ameliorates monocrotaline-induced pulmonary arterial
hypertension in rats. Biomed Rep. 3:537–542. 2015.PubMed/NCBI
|
|
19
|
Xu XF, Ma XL, Shen Z, Wu XL, Cheng F and
Du LZ: Epigenetic regulation of the endothelial nitric oxide
synthase gene in persistent pulmonary hypertension of the newborn
rat. J Hypertens. 28:2227–2235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fabris VE, Pato MD and Belik J:
Progressive lung and cardiac changes associated with pulmonary
hypertension in the fetal rat. Pediatr Pulmonol. 31:344–353. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu XF, Gu WZ, Wu XL, Li RY and Du LZ:
Fetal pulmonary vascular remodeling in a rat model induced by
hypoxia and indomethacin. J Matern Fetal Neonatal Med. 24:172–182.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stayer SA and Liu Y: Pulmonary
hypertension of the newborn. Best Pract Res Clin Anaesthesiol.
24:375–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dakshinamurti S: Pathophysiologic
mechanisms of persistent pulmonary hypertension of the newborn.
Pediatr Pulmonol. 39:492–503. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cabral JE and Belik J: Persistent
pulmonary hypertension of the newborn: Recent advances in
pathophysiology and treatment. J Pediatr (Rio J). 89:226–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nair J and Lakshminrusimha S: Update on
PPHN: Mechanisms and treatment. Semin Perinatol. 38:78–91. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lemmers PM, Benders MJ, D'Ascenzo R,
Zethof J, Alderliesten T, Kersbergen KJ, Isgum I, de Vries LS,
Groenendaal F and van Bel F: Patent ductus arteriosus and brain
volume. Pediatrics. 137:pii: e201530902016. View Article : Google Scholar
|
|
28
|
Louis D, Torgalkar R, Shah J, Shah PS and
Jain A: Enteral feeding during indomethacin treatment for patent
ductus arteriosus: Association with gastrointestinal outcomes. J
Perinatol. 36:544–548. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dodson RB, Morgan MR, Galambos C, Hunter
KS and Abman SH: Chronic intrauterine pulmonary hypertension
increases main pulmonary artery stiffness and adventitial
remodeling in fetal sheep. Am J Physiol Lung Cell Mol Physiol.
307:L822–L828. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Konduri GG, Bakhutashvili I, Eis A and
Afolayan A: Antenatal betamethasone improves postnatal transition
in late preterm lambs with persistent pulmonary hypertension of the
newborn. Pediatr Res. 73:621–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang K, Lu W, Jia J, Zhang J, Zhao M, Wang
S, Jiang H, Xu L and Wang J: Noggin inhibits hypoxia-induced
proliferation by targeting store-operated calcium entry and
transient receptor potential cation channels. Am J Physiol Cell
Physiol. 308:C869–C878. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun H, Xia Y, Paudel O, Yang XR and Sham
JS: Chronic hypoxia-induced upregulation of
Ca2+-activated Cl channel in pulmonary arterial
myocytes: A mechanism contributing to enhanced vasoreactivity. J
Physiol. 590:3507–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng G, Wang J, Lu W and Ran P: Isolation
and primary culture of rat distal pulmonary venous smooth muscle
cells. Hypertens Res. 33:308–313. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jone PN, Patel SS, Cassidy C and Ivy DD:
Three-dimensional echocardiography of right ventricular function
correlates with severity of pediatric pulmonary hypertension.
Congenit Heart Dis. 11:562–569. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim EK, Lee JH, Oh YM, Lee YS and Lee SD:
Rosiglitazone attenuates hypoxia-induced pulmonary arterial
hypertension in rats. Respirology. 15:659–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nisbet RE, Bland JM, Kleinhenz DJ,
Mitchell PO, Walp ER, Sutliff RL and Hart CM: Rosiglitazone
attenuates chronic hypoxia-induced pulmonary hypertension in a
mouse model. Am J Respir Cell Mol Biol. 42:482–490. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo Q, Huang JA, Yamamura A, Yamamura H,
Zimnicka AM, Fernandez R and Yuan JX: Inhibition of the
Ca(2+)-sensing receptor rescues pulmonary hypertension in rats and
mice. Hypertens Res. 37:116–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yun X, Chen Y, Yang K, Wang S, Lu W and
Wang J: Upregulation of canonical transient receptor potential
channel in the pulmonary arterial smooth muscle of a chronic
thromboembolic pulmonary hypertension rat model. Hypertens Res.
38:821–828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang J, Weigand L, Lu W, Sylvester JT,
Semenza GL and Shimoda LA: Hypoxia inducible factor 1 mediates
hypoxia-induced TRPC expression and elevated intracellular
Ca2+ in pulmonary arterial smooth muscle cells. Circ
Res. 98:1528–1537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lotfi K, Karlsson K, Fyrberg A, Juliusson
G, Jonsson V, Peterson C, Eriksson S and Albertioni F: The pattern
of deoxycytidine- and deoxyguanosine kinase activity in relation to
messenger RNA expression in blood cells from untreated patients
with B-cell chronic lymphocytic leukemia. Biochem Pharmacol.
71:882–890. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Yang K, Xu L, Zhang Y, Lai N,
Jiang H, Zhang Y, Zhong N, Ran P and Lu W: Sildenafil inhibits
hypoxia-induced transient receptor potential canonical protein
expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ
axis. Am J Respir Cell Mol Biol. 49:231–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
